Simplex Trading, LLC
- SEC CIK
- 0001488542
- Latest filing
- Aug 12, 2026
GANX holding history
Gain Therapeutics, Inc. in every 13F filed by Simplex Trading, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GANX overviewAll 13F holders of GANXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −13,439−100.0% | Sold out | Holders |
| Q1 2026 | 13,439 | $26.1K | <0.1% | −34,507−72.0% | Reduced | Holders |
| Q4 2025 | 47,946 | $154.4K | <0.1% | +47,946 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −5,657−100.0% | Sold out | Holders |
| Q2 2025 | 5,657 | $10.0K | <0.1% | +2,213+64.3% | Added | Holders |
| Q1 2025 | 3,444 | $6.00K | <0.1% | +3,444 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −4,801−100.0% | Sold out | Holders |
| Q3 2024 | 4,801 | $8.00K | <0.1% | −4,258−47.0% | Reduced | Holders |
| Q2 2024 | 9,059 | $11.0K | <0.1% | −8,924−49.6% | Reduced | Holders |
| Q1 2024 | 17,983 | $67.0K | <0.1% | +17,983 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −8,650−100.0% | Sold out | Holders |
| Q3 2023 | 8,650 | $28.0K | <0.1% | +8,650 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −100−100.0% | Sold out | Holders |
| Q3 2022 | 100 | $0 | 0.0% | +100 | New | Holders |